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Summary
Themammalian target of rapamycin (mTOR) is a serine/
threonine kinase that participates in at least two dis-
tinct multiprotein complexes, mTORC1 and mTORC2
[1]. These complexes play important roles in the regu-
lation of cell growth, proliferation, survival, andmetab-
olism. mTORC2 is a hydrophobic motif kinase for
the cell-survival protein Akt/PKB [2, 3] and, here, we
identify mSin1 as a component of mTORC2 but not
mTORC1. mSin1 is necessary for the assembly of
mTORC2 and for its capacity to phosphorylate Akt/
PKB. Alternative splicing generates at least five iso-
formsof themSin1protein [4], threeofwhich assemble
into mTORC2 to generate three distinct mTORC2s.
Even though all mTORC2s can phosphorylate Akt/
PKB in vitro, insulin regulates the activity of only two
of them. Thus, we propose that cells contain several
mTORC2 flavors that may phosphorylate Akt/PKB in
response to different signals.
Results and Discussion
mSin1 Is a Novel Component of mTORC2
but Not mTORC1
To identify new components of the mammalian target of
rapamycin (mTOR) complexes, we generated HEK-293T
cells that stably express N-terminally tandem affinity
purification (TAP)-tagged mLST8, a component of both
mTORC1 and mTORC2, and used these to perform large-
scale tandem affinity purifications [5]. Because we were
interested in identifying components that were unique
to mTORC1 or mTORC2, we also generated cell lines ex-
pressing TAP-tagged raptor. From these purifications,
we identified, via tandem mass spectrometry, the protein
mSin1 (mammalian stress-activated protein kinase
[SAPK]-interacting protein) [6] as a novel component of
mTORC2 but not mTORC1. To confirm the identity of
*Correspondence: sabatini@wi.mit.edumSin1, we immunoblotted a small amount of each purifi-
cation with a specific anti-human mSin1 antibody and
showed that at least three isoforms of mSin1 are present
in the TAP-mLST8 material (Figure 1A). To further char-
acterize this interaction, we also performed immunopuri-
fications with antibodies that specifically recognize
mTOR, rictor, and raptor from total-cell extracts of
HeLa and HEK-293T cells (Figure 1B). In agreement
with the tandem affinity purifications, we verified that at
least two endogenous mSin1 isoforms coimmuno-
precipitate with endogenous mTOR and rictor but not
with raptor.
mSin1, also known as MAPKAP1 (mitogen-activated
protein kinase-associated protein 1), was originally
identified (clone JC-310) in an expression screen for
its ability to suppress the phenotypes generated in
S. cerevisiae by the expression of a constitutively active
human Ha-Ras mutant [7]. mSin1 likely belongs to a
poorly conserved family of proteins that include Sin1 in
S. pombe, AVO1 in S. cerevisiae, and RIP3 in D. discoi-
deum [4]. Protein conservation among the Sin1 family
members is mostly limited to a small region correspond-
ing to residues 225 to 267 of the longest mSin1 protein.
Contrasting with other species in which Sin1 has been
studied, human mSin1 is unique in having five different
protein isoforms, generated by alternative splicing [4]
(Figure 2A). Importantly, AVO1 has been identified as a
component of the yeast TORC2 [8], and RIP3 has been
shown to bind to Pia (rictor), which is a TORC2 compo-
nent in D. discoideum [9]. Although an interaction be-
tween mSin1 and mTOR was suspected, a previous
attempt to show this association was unsuccessful [8],
and thus our work provides the first evidence that en-
dogenous mSin1 is a component of mTORC2 but not
mTORC1.
We next asked whether mSin1 is also an mTORC2
component in eight different human cancer cell lines
(Figure 1C). Different amounts of two mSin1 isoforms
were detected in both mTOR immunopurifications and
total-cell lysates made from all cell lines tested. Except
for HeLa cells, these cell lines express low levels of iso-
form 2, which can only be seen after the enrichment
through an mTOR immunopurification. These findings
suggest that at least two mSin1 isoforms are expressed
ubiquitously, though in different amounts, in several hu-
man cell lines. This is consistent with previous studies
showing that several mSin1 isoforms exist in different
human tissues [8, 10]. We conclude that at least two en-
dogenous isoforms of mSin1 coimmunoprecipitate with
mTOR and rictor but not raptor, and that, therefore,
mSin1 is a component of mTORC2.
mSin1 Isoforms 1, 2, and 5 Assemble Separately into
mTORC2 and Define Three Distinct Complexes
Human mSin1 is functionally related to yeast AVO1 even
though they have diverged considerably. To determine
potential functional differences between the isoforms,
we used HEK-293T-derived stable cell lines expressing
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(A) Detection by immunoblotting of indicated proteins in affinity purifications of TAP alone and of TAP-mLST8 and TAP-raptor fusion proteins.
(B) mTOR, rictor, and raptor immunopurifications prepared from HeLa and HEK-293T cells were analyzed by immunoblotting for the levels of
endogenous mSin1 and other mTORC1 and mTORC2 proteins, as indicated.
(C) mTOR immunopurifications made from lysates of eight different human cancer cell lines were analyzed by immunoblotting for the levels of
indicated proteins.C-terminally myc-tagged versions of mSin1.1, 1.2, 1.4,
and 1.5 isoforms. mSin1.3 was not included because
we could not verify its expression by RT-PCR in mRNA
obtained from HeLa and HEK-293T cells (Figure S1 in
the Supplemental Data available online and data not
shown). In immunoblot analysis of cells expressing re-
combinant isoforms, our mSin1 antibody recognized
four different mSin1 bands with apparent molecular
weights of approximately 80, 76, 55, and 52 kDa, which
correspond respectively to isoforms 1, 2, 5, and 4
(Figure 2B). Interestingly, all isoforms have an apparent
molecular weight that is higher than predicted. Addition-
ally, isoform 5 shows a higher electrophoretic mobility
than isoform 4, even though its predicted weight is less.
Using the stable cell lines expressing each myc-tagged
mSin1 isoform or g-tubulin, we performed immunopuri-
fications with rictor, raptor, mTOR, and myc antibodies.
We found that rictor immunopurifications contain iso-
forms 1, 2, and 5 (Figure 2C, left panel). mTOR immuno-
purifications also contain each of these isoforms (data
not shown), whereas raptor immunopurifications do
not (Figure 2C, right panel). In agreement with these
findings, immunopurifications of myc-tagged isoforms
1, 2, and 5 coimmunoprecipitate mTOR and rictor but
not raptor (Figure 2D, left panels). Isoform 4 does not
coimmunoprecipitate with mTOR, rictor, or raptor. Our
finding that isoform 5 coimmunoprecipitates mTOR
and rictor confirmed our TAP results (Figure 1A) that
isoform 5 can participate in mTORC2. It was not possi-
ble to detect it in the mTOR and rictor immunopurifica-
tions because isoform 5 migrates at a molecular weight
similar to IgG and would have been masked by back-
ground bands in immunoblots (Figure 1B). The discov-
ery that three mSin1 isoforms can participate in
mTORC2 raised the question of whether the threeisoforms bind simultaneously or whether, instead, they
bind exclusively to form three distinct mTORC2s, each
defined by a different mSin1 isoform. To answer this
question, we probed the myc immunopurifications of
the mSin1 isoforms with an antibody for human mSin1.
Our rationale was that if multiple isoforms bound simul-
taneously, we would see more than one mSin1 band in
each of the myc immunopurifications. However, each
myc immunopurification contained only a single mSin1
band, identical to the molecular weight of the myc-
tagged isoform we expressed (Figure 2D, right panel).
Our results suggest that there are at least three distinct
mTORC2s, each of them defined by a specific mSin1
isoform, and uncover an unforeseen complexity of
mTORC2 relative to other TORC2s. Inspection of the
mSin1 isoform sequences (Figure 2A) revealed that the
main difference between isoform 4 and the remaining
isoforms, including the isoforms that assemble into
mTORC2s, is the lack of the first 192 amino acid resi-
dues. This suggests that an unknown domain contained
within the first 192 amino acids of the mSin1 proteins
may be responsible for their assembly into mTORC2.
Our unpublished data, showing that N-terminally myc-
tagged mSin1 isoforms 1, 2, and 5 cannot enter
mTORC2, also lead to the idea that the N-terminal region
of the mSin1 proteins may be critical for binding to
mTORC2 components during complex assembly. The
use of N-terminally myc-tagged mSin1 isoforms may
have hampered previous attempts to show that mSin1
is part of mTORC2 [8]. The potential importance of the
N terminus was unexpected because all Sin1 ortholog
proteins share a small region that does not overlap
with the first 192 amino acid residues of mSin1 and
could have been anticipated to be associated with their
ability to bind to mTORC2.
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1867Figure 2. mSin1.1, mSin1.2 and mSin1.5, Three Different Protein Isoforms of mSin1, Define Three Distinct mTORC2s
(A) Schematic representation of the human Sin1 gene, transcript variants, and protein isoforms. Six mSin1 transcript variants, generated by
alternative splicing, encode five different mSin1 protein isoforms. Two transcript variants encode for mSin1 isoform 4.
(B) Detection of C-terminally myc-tagged mSin1.1, mSin1.2, mSin1.4, mSin1.5, and g-tubulin levels in lysates of HEK-293T-derived cells stably
expressing each recombinant protein by immunoblotting with an antibody to the myc tag (left panel) or to mSin1 (right panel).
(C) Rictor and raptor immunopurifications made from lysates of cells described in (B) were analyzed by immunoblotting for the levels of
myc-tagged proteins and other mTORC1 and mTORC2 proteins, as indicated.
(D) Myc immunopurifications made from lysates of cells described in (B) were analyzed by immunoblotting with antibodies to the myc tag, mTOR,
rictor, raptor (left panel), and mSin1 (right panel).Recent studies provide genetic [11] and biochemical
[12, 13] evidence suggesting that TOR complexes may
work as dimers or even higher-order multimers. To
understand whether the different mSin1-containing
mTORC2s oligomerize with each other, we coexpressed,
in HEK-293T cells, mSin1.1 tagged with an HA epitope
along with one of the following proteins: mSin1.1-myc,
mSin1.2-myc, mSin1.5-myc, or g-tubulin-myc. In immu-
nopurifications prepared with either the hemagglutinin
(HA) or myc antibody, we detected the mSin1 isoform di-
rectly immunoprecipitated by the antibody as well as the
mTOR and rictor components of mTORC2 (Figure S2). In
no case did we detect the coexpressed mSin1 isoform
that was tagged with the epitope recognized by the anti-
body not used in the immunoprecipitation. These results
suggest that under our purification conditions mTORC2
is not a dimer and are consistent with our assertion
that only one mSin1 protein can participate in mTORC2
at a time. Overall, our data support the idea that even
though made with similar components, mTORC2 might
be more complex than other TORC2s because it exists
in at least three different formats.
Sin1 Is Essential for the Phosphorylation
of the Hydrophobic-Motif Site of Akt/PKB
Because mTORC2 phosphorylates the hydrophobic-
motif site Serine-473 of Akt/PKB [2], we asked whether
mSin1 is required for this process. To test this hypothe-
sis, we used short-hairpin-mediated RNA interferenceto knock down mSin1 in both HEK-293T and HeLa cells
(Figure 3A). Knockdown of mSin1 with these two differ-
ent shRNAs severely inhibited the phosphorylation of
Ser473-Akt/PKB without affecting that of Thr389 of
S6K1. We observed the same effect by knocking down
rictor, whereas a control shRNA had no effect on Akt/
PKB. Interestingly, the knockdown of mSin1 also leads
to a reduction in rictor protein levels, suggesting that
mSin1 is required for either rictor expression or stabiliza-
tion and therefore assembly into mTORC2. This is likely
to be the main reason why rictor is absent from mTOR im-
munopurifications made from mSin1-knocked-down
cells (Figure 3A, bottom panels). We also found a reduc-
tion in mSin1 protein levels in lysates made from rictor-
knocked-down cells. Decreased rictor protein levels in
the absence of mSin1, and vice versa, suggest a code-
pendence between the two components for complex
formation and have previously been observed for
TORC2 components in yeast [12].
To test whether the role of Sin1 in the phosphorylation
of Akt/PKB is evolutionarily conserved, we performed
similar knockdown experiments with two different
double-stranded RNAs that target the dSin1 transcript
in Drosophila Kc167 cells (Figure 3B). dsRNA to dSin1
completely abolishes the phosphorylation of the hydro-
phobic-motif site Ser-505 of dAkt/PKB. This was still
true when the dAkt/PKB-suppressor, dPTEN, was also
knocked down, underscoring the importance of dSin1
in dAkt/PKB phosphorylation.
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1868Figure 3. mSin1 Is Required for mTORC2 Assembly and Phosphorylation of the Hydrophobic-Motif Site (Ser473) of Akt/PKB
(A) mSin1 was silenced in HeLa and HEK-293T cells with indicated shRNAs, and cell lysates were analyzed by immunoblotting for the levels of
indicated proteins and phosphorylation states (upper panels) . mTOR immunopurifications made from lysates of shRNA-expressing cells were
also analyzed by immunoblotting for the levels of mSin1, mTOR, rictor, and raptor (lower panels).
(B) dsRNA-mediated gene silencing of dSin1 in D.melanogaster Kc167 cells, performed individually or simultaneously with dPTEN gene silenc-
ing. Lysates of dsRNA-treated cells were analyzed by immunoblotting for the levels of indicated proteins and phosphorylation states.
(C) Three distinct and mSin1-defined mTORC2s have the ability to phosphorylate the hydrophobic motif of Akt/PKB in vitro. Myc immunopuri-
fications of each mTORC2, made from lysates of HEK-293T cells stably expressing each myc-tagged mSin1 isoform, were used to phosphorylate
in vitro full-length Akt1/PKB1. Levels of phospho-Ser473-Akt/PKB and other indicated proteins were detected by immunobloting.Because our shRNAs target most, but not all, mSin1
isoforms simultaneously, we cannot determine whether
different isoforms play different roles in mediating Akt/
PKB phosphorylation. Because of extensive sequence
overlap between mSin1 transcript variants (Figure 2A),
it is not possible to silence each isoform individually
with RNAi. To investigate possible functional differences
between the isoforms, we had to use a different ap-
proach. Using cell lysates from HEK-293T cells stably
expressing mSin1 isoforms, we tested myc immunopre-
cipitates for their ability to phosphorylate full-length Akt/
PKB in vitro (Figure 3C). Rictor and raptor immunopuri-
fications were also included as positive and negative
controls, respectively. Through this system we were
able to show that complexes containing mSin1 isoforms
1, 2, and 5 can directly phosphorylate Akt/PKB, just like
complexes containing rictor, but not raptor. Interest-
ingly, the levels of Akt/PKB phosphorylated in vitro
were similar among the different mSin1-containing com-
plexes, even though mSin1 isoforms 1, 2, and 5 are pres-
ent at different levels. This suggests that the levels of
mTOR, as the catalytic subunit of mTORC2, most likely
determine the activity of the complex.Our findings provide in vivo biochemical and physio-
logical evidence that is consistent with an mSin1-con-
taining mTORC2 (that exists in three forms) being the
hydrophobic motif kinase of Akt/PKB and that this func-
tion is conserved between species. In agreement with
this, a study of the Dictyostelium signaling pathways in-
volved in chemotaxis and signal relay showed that Akt/
PKB purified from rip3 (mSin1) null cells had less activity
than in wild-type cells [9].
Insulin Activates Only Two of the Three mTORC2s
Having shown that three mSin1 isoforms can be compo-
nents of three distinct mTORC2s, all with the ability to
phosphorylate the hydrophobic-motif site Ser473 of
Akt/PKB, and considering that Ser473 phosphorylation
is stimulated by insulin [14], we next determined whether
the activity of all three mTORC2s is insulin sensitive. To
answer this question, we performed in vitro kinase
assays with immunopurifications of each mSin1 isoform
from lysates of HeLa cells grown overnight under serum
starvation or stimulated with 100 nM insulin for 20 min
(Figure 4A and Figure S3B). We found that only
mSin1.1- and mSin1.2-containing mTORC2s modulate
Distinct mSin1-Defined mTORC2s Phosphorylate Akt
1869Figure 4. Regulation of mSin1-Containing mTORC2s by Insulin and Rapamycin
(A) mTORC2s containing mSin1.1 and mSin1.2, but not mSin1.5, phosphorylate the hydrophobic motif of Akt/PKB in response to insulin. Myc
immunopurifications of each of the mSin1-containing mTORC2s, made from lysates of HeLa cells stably expressing each myc-tagged mSin1
isoform and grown under serum starvation or insulin-stimulated conditions, were used to phosphorylate in vitro full-length Akt1/PKB1. Levels
of in vitro phosphorylated (Ser473) Akt/PKB, as well as other indicated proteins, were detected by immunoblotting.
(B) Chronic rapamycin affects mSin1 assembly into mTORC2. HEK-293T and HeLa cells were treated for 1 hr or 24 hr with 100 nM rapamycin. Cell
lysates (lower panels) and mTOR immunopurifications (upper panels) made from cell lysates were analyzed by immunoblotting for the levels
mSin1 and other indicated proteins.
(C) Proposed model for three distinct mSin1-containing mTORC2s.their activity in response to insulin. Identical in vitro ki-
nase assays performed with rictor immunopurifications
also showed that insulin activates the in vitro phosphor-
ylation of Ser473 of Akt/PKB by mTORC2 (Figure S3A).
Recently, it has been suggested that phosphatidylinosi-
tol (3,4,5)-trisphosphate (PIP3,4,5) may regulate the ca-
pacity of mTORC2 to phosphorylate Akt/PKB [3]. How-
ever, the addition of PIP3,4,5 to in vitro mTOR kinase
reactions did not lead to any alteration in the capacity
of mTORC2 to phosphorylate Akt/PKB (Figure S3C).
Surprisingly, the mTORC2 containing mSin1.5 is insensi-
tive to serum starvation and insulin stimulation, as shown
by its constitutive capacity to phosphorylate the Ser473
site of Akt/PKB under both conditions. It is known that
Akt/PKB phosphorylation is regulated by PIP3,4,5-
driven membrane localization [14], and even though the
mSin1.5-containing mTORC2 retains activity toward
Akt/PKB in the absence of insulin, it may not be localized
where it has access to Akt/PKB. It is also possible that
the normal role of mSin1.5-containing mTORC2 is not
to respond to insulin and that it regulates Akt/PKB in re-
sponse to other signals or signals to other molecules
altogether. In S. pombe, Sin1 interacts with Sty1 (the fis-
sion-yeast ortholog of mammalian SAPKs, JNK, and p38)
and is required for Sty1-mediated activation of the
stress-induced transcription factors Atf1 and Pap1. It is
thus possible that the mSin1.5-containing mTORC2
plays a role in stress signaling. Recent studies [10, 15]
have shown that mSin1 isoforms 1 and 5 can interact
with proteins of the mammalian SAPK signaling cas-
cade, where mSin1 seems to have an inhibitory effect.
Although Sin1 seems to be implicated in stress signaling,
contradictory results obtained in fission-yeast and mam-
malian studies make the role of Sin1 in stress responses
yet to be established. Our results open the possibility
that different mSin1-containing mTORC2s may regulate
Akt/PKB in response to different signals, but this remains
to be proven.Chronic Rapamycin Affects mSin1
Assembly into mTORC2
Chronic rapamycin treatment has recently been shown
to affect the assembly of mTORC2 [16]. The mTOR-rictor
interaction was severely disrupted in several human
cancer cell lines grown in the presence of rapamycin
for at least 24 hr. Because we have shown that mSin1
is an mTORC2 component, we wanted to understand
whether the mSin1-mTOR interaction is also sensitive
to chronic rapamycin treatment. For that, we challenged
both HEK-293T and HeLa cells with acute or chronic ra-
pamycin treatments (100 nM), of 1 hr and 24 hr, respec-
tively. We observed that after 24 hr, rapamycin disrupts
the interaction between endogenous mTOR and the
mSin1.1 and mSin1.2 isoforms (Figure 4B). This sup-
ports the idea that even though rapamycin cannot bind
to mTOR when assembled into mTORC2, it can bind to
mTOR when assembled into mTORC1 or before assem-
bling into any of the complexes. As mTORC2 turnover
proceeds, the amount of free mTOR available to bind
to mSin1 and the other mTORC2 components is strongly
reduced, thus explaining the mTORC2 decay after long-
term exposure to rapamycin. Our data indicate that the
loss of mSin1 expression leads to a loss of rictor expres-
sion (Figure 3A), but the disruption of mTORC2 by long-
term rapamycin treatment has no effect on rictor expres-
sion. One possible explanation for this is that mSin1 and
rictor make within cells a weak interaction that is re-
quired to maintain their stability but is independent of
mTOR. When cells are chronically treated with rapamy-
cin, rictor and mSin1 are displaced from mTOR, but still
may be available to interact with each other, although
we currently have no evidence for this. On the other
hand, when the expression of either mSin1 or rictor is
knocked down by RNAi, this putative interaction would
no longer be possible. It is also possible that mSin1
and/or rictor have mTOR-independent roles that are
not affected by rapamycin but are lost when the
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not exclude the possibility that long-term treatment with
rapamycin disrupts mTORC2 because rapamycin in-
hibits the synthesis of a short-lived protein that is neces-
sary for complex assembly.
With this work, we propose that the multiple isoforms
of mSin1 (mSin1.1, mSin1.2, and mSin1.5) define several
unique mTORC2s, adding a functional complexity that
seems to be absent in TORC2 signaling in other species.
Additionally, our findings suggest that different mSin1
isoforms might mediate Akt/PKB (Ser473) phosphoryla-
tion in response to different upstream signals. Specifi-
cally, the activity of the mSin1.5-containing mTORC2
is not affected by insulin stimulation and might even
not be associated with growth-factor signaling to Akt/
PKB. However, we have not yet identified which stimuli
do signal to Akt/PKB (Ser473) through this complex.
Furthermore, the fact that both mSin1.1- and mSin1.2-
containing mTORC2s regulate Ser473-Akt/PKB phos-
phorylation does not exclude the possibility that in the
presence of other signals they might perform differently,
thus supporting the idea of different mTORC2s being
involved in the phosphorylation of the hydrophobic-
motif site of Akt/PKB in response to specific upstream
signals.
Supplemental Data
Supplemental Data include Experimental Procedures and are avail-
able with this article online at: http://www.current-biology.com/cgi/
content/full/16/18/1865/DC1/.
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